Business Wire6m
Blue Lake Biotechnology Reports Additional Promising Clinical Data from Ongoing Pediatric Clinical Study of Intranasal RSV Vaccine BLB201
Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing parainfluenza virus 5 (PIV5)-vectored ...
Flu cases are already three and a half times what they were last year
NHS leaders warn that hospitals are bracing for a 'quad-demic' of disease over the winter months with the number of daily flu ...